PULMATRIX, INC. Proceeds from (Repayments of) Debt
PULMATRIX, INC. (PULM) reported Proceeds from (Repayments of) Debt of -$3.26 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2020-03-26
- PULMATRIX, INC. proceeds from (repayments of) debt for the quarter ending 2018-12-31 was $0.00.
- PULMATRIX, INC. proceeds from (repayments of) debt for the quarter ending 2018-09-30 was $0.00.
- PULMATRIX, INC. proceeds from (repayments of) debt for the quarter ending 2018-06-30 was -$2.54M.
- PULMATRIX, INC. proceeds from (repayments of) debt for the quarter ending 2018-03-31 was -$719.00K.
- PULMATRIX, INC. proceeds from (repayments of) debt for fiscal 2018 was -$3.26M.
- PULMATRIX, INC. proceeds from (repayments of) debt for fiscal 2017 was -$2.69M.
- PULMATRIX, INC. proceeds from (repayments of) debt for fiscal 2016 was -$1.05M, a 115.14% decline from fiscal 2015.
- PULMATRIX, INC. proceeds from (repayments of) debt for fiscal 2015 was $6.91M.
| Period end | Proceeds from (Repayments of) Debt 3 month | Proceeds from (Repayments of) Debt 6 month | Proceeds from (Repayments of) Debt 9 month | Proceeds from (Repayments of) Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | -$2.54M derived: sum of 3 quarters · filed 2020-03-26 | -$3.26M 10-K · filed 2020-03-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$2.54M derived: sum of 2 quarters · filed 2019-11-01 | -$3.26M 10-Q · filed 2019-11-01 | -$3.96M derived: sum of 4 quarters · filed 2019-11-01 |
| 2018-06-30 | -$2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$3.26M 10-Q · filed 2019-08-05 | -$3.96M derived: sum of 3 quarters · filed 2019-08-05 | -$4.64M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | -$719.00K 10-Q · filed 2019-05-15 | -$1.42M derived: sum of 2 quarters · filed 2019-05-15 | -$2.10M derived: sum of 3 quarters · filed 2019-05-15 | -$2.76M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$1.38M derived: sum of 2 quarters · filed 2019-02-19 | -$2.04M derived: sum of 3 quarters · filed 2019-02-19 | -$2.69M 10-K · filed 2019-02-19 |
| 2017-09-30 | -$680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.34M derived: sum of 2 quarters · filed 2018-11-14 | -$2.00M 10-Q · filed 2018-11-14 | -$2.63M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$664.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$1.31M 10-Q · filed 2018-08-03 | -$1.95M derived: sum of 3 quarters · filed 2018-08-03 | |
| 2017-03-31 | -$651.00K 10-Q · filed 2018-05-11 | -$1.28M derived: sum of 2 quarters · filed 2018-05-11 | ||
| 2016-12-31 | -$634.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$1.05M 10-K · filed 2018-03-13 | ||
| 2016-09-30 | -$412.00K 10-Q · filed 2017-11-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $6.91M 10-K · filed 2017-03-10 | ||
| 2015-09-30 | $6.91M 10-Q · filed 2016-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |